Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents.
Noberasco C, Spitaleri G, Mancuso P, Zorzino L, Radice D, Milani A, Rocca A, Bertolini F, Sandri MT, Curigliano G, de Pas T, Jemos C, Omodeo Salè E, Boselli S, de Braud F.
Noberasco C, et al. Among authors: sandri mt.
Oncology. 2009;77(6):358-65. doi: 10.1159/000275830. Epub 2010 Jan 11.
Oncology. 2009.
PMID: 20068365
Clinical Trial.